Skip to content
Learn Motion
ExploreHow it worksMembership
Log in
Learn Motion

Can AI Discover New Drugs? A High-Level Overview

1Why Drug Discovery Is Hard, and Where AI Fits2How AI Learns From Molecules and Proteins3Finding and Validating a Biological Target4Designing Molecules: Generative AI and Virtual Screening5From Hit to Lead: Optimizing Properties With AI6What AI Still Cannot Do7Judging the Claims: Real Successes, Failures, and Open Questions
Finding and Validating a Biological Target

Why the Ranking Is Not the Answer

4 / 4
The ranking is a set of hypotheses, not a result. Validation means showing that modulating the target actually changes disease-relevant biology — that it is expressed where the disease occurs, that blocking or activating it produces the expected cellular effect, and that the effect holds in a disease model rather than only in an artificial assay. Why can't the model skip this? Because genetics, literature, and omics all describe what has already been observed. None of them tests whether intervening on this protein in a living system will change the disease. So the real value of AI here is not that it produces correct targets — it is that it narrows the field, cutting down how many hypotheses need experimental testing.
0:00 / 0:00

A ranked target list is a set of hypotheses ordered by evidence, not a confirmed result. The distance between a high rank and a validated target is the distance between association and causation, and only experiments close it.

What experimental validation typically establishes

  • The target is expressed in the tissue and cell type where the disease occurs
  • Modulating the target — blocking or activating it — produces the expected change in disease-relevant cellular behavior
  • The effect holds in a disease model, not only in an artificial assay system
  • The result is reproducible and not an artifact of one experimental setup

Why computational evidence cannot substitute for this step

Genetics, literature, and omics all describe what has already been observed in populations, published experiments, or collected samples. None of them directly tests whether intervening on this protein in a living system will change the disease. That intervention test is exactly what validation supplies, and it is why targets are confirmed experimentally before a program commits to years of molecule design and optimization.

AI's contribution at this stage is not producing correct targets but narrowing the field of plausible ones. A ranking that reliably places the right target in the top handful is valuable even though every candidate in that handful still requires experimental confirmation.

Previous4 / 4Next

Learn Motion

Generate a course. Learn it properly.

Operated by Wuhan Daoyin Technology Co., Ltd.

Contact: [email protected]
Privacy PolicyTerms of Service

© 2026 Learn Motion